Corrigendum to ‘Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer’ [Mater. Today Bio 33 (2025) 101993]

Yue Huang; Kui Wang; Mengjun Yu; Qiang Zhou; Jia Wang; Shiwen Chen; Jing Gong; Min Yang; Jingbin Huang; Yu Zhao

doi:10.1016/j.mtbio.2025.102067

. 2026 Mar 17;37:102067. doi: 10.1016/j.mtbio.2025.102067

Corrigendum to ‘Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer’ [Mater. Today Bio 33 (2025) 101993]

Yue Huang ^a,¹, Kui Wang ^b,¹, Mengjun Yu ^b, Qiang Zhou ^a, Jia Wang ^a, Shiwen Chen ^a, Jing Gong ^b, Min Yang ^b, Jingbin Huang ^b,^⁎, Yu Zhao ^a,^⁎⁎

PMCID: PMC13037546 PMID: 41923984

The authors regret < In Acknowledgments, the Jingbin. Huang 's fund number was filled in incorrectly by CSTB2024NSCQ-MSX0196, and the correct fund number should be CSTB2022NSCQ-MSX0201.>.

The authors would like to apologise for any inconvenience caused.

Contributor Information

Jingbin Huang, Email: sige@tmmu.edu.cn.

Yu Zhao, Email: zhaoyuu@hotmail.com.

PERMALINK

Corrigendum to ‘Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer’ [Mater. Today Bio 33 (2025) 101993]

Yue Huang

Kui Wang

Mengjun Yu

Qiang Zhou

Jia Wang

Shiwen Chen

Jing Gong

Min Yang

Jingbin Huang

Yu Zhao

Contributor Information

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Corrigendum to ‘Co-delivery paclitaxel and IR783 as nanoparticles for potentiated chemo-photothermal-immunotherapy of triple-negative breast cancer’ [Mater. Today Bio 33 (2025) 101993]

Yue Huang

Kui Wang

Mengjun Yu

Qiang Zhou

Jia Wang

Shiwen Chen

Jing Gong

Min Yang

Jingbin Huang

Yu Zhao

Contributor Information

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases